Maternal serum levels of asymmetric dimethylarginine in normal and preeclamptic pregnancies

References

• Lindheimer MD, Taler SJ, Cunningham FG. American Society of Hypertension. ASH position paper: hypertension in pregnancy. J Clin Hypertens (Greenwich). 2009;11(4):214–225.
   PubMed Web of Science ®Google Scholar
• Dusse LM, Rios DR, Pinheiro MB, et al. Pre-eclampsia: relationship between coagulation, fibrinolysis and inflammation. Clin Chim Acta. 2011;412(1–2):17–21.
   PubMed Web of Science ®Google Scholar
• Brennan LJ, Morton JS, Davidge ST. Vascular dysfunction in preeclampsia. Microcirculation. 2014;21(1):4–14.
   PubMed Web of Science ®Google Scholar
• Franceschelli S, Ferrone A, Pesce M, et al. Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease. IJMS. 2013;14(12):24412–24421.
   Google Scholar
• Chen S, Li N, Deb-Chatterji M, et al. Asymmetric dimethylarginine as marker and mediator in ischemic stroke. IJMS. 2012;13(12):15983–16004.
   Google Scholar
• Lyall F, Jablonka-Shariff A, Johnson RD, et al. Gene expression of nitic oxide synthase in cultured term placental trophoblast during in vitro differentiation. Placenta. 1998;19(4):253–260.
   PubMed Web of Science ®Google Scholar
• Cooke JP. Asymmetrical dimethylarginine: the Uber marker? Circulation. 2004;109(15):1813–1819.
   PubMed Web of Science ®Google Scholar
• Huang LT, Hsieh CS, Chang KA, et al. Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming. IJMS. 2012;13(12):14606–14622.
   Google Scholar
• Power RW, Speer PD, Frank MP, et al. Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia but not pregnancies with small for gestational age infants. Am J Obstet Gynecol. 2008;198(1):112.e1–7.
   Web of Science ®Google Scholar
• Alpoim PN, Godoi LC, Freitas LG, et al. Assessment of l-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia. Nitric Oxide. 2013;33:81–82.
   PubMed Web of Science ®Google Scholar
• Lawskowska M, Lawskowska K, Terbosh M, et al. A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies. Med Sci Monit. 2013;19:430–437.
   PubMed Web of Science ®Google Scholar
• Yuan J, Wang X, Xie Y, et al. Circulating asymmetric dimethylarginine and the risk of preeclampsia: a meta-analysis based on 1338 participants. Oncotarget. 2017;8(27):43944–43952.
   PubMedGoogle Scholar
• Pettersson A, Hedner T, Milsom I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in pre-eclampsia. Acta Obstet Gynecol Scand. 1998;77(8):808–813.
   PubMed Web of Science ®Google Scholar
• Mao D, Che J, Li K, et al. Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Arch Gynecol Obstet. 2010;282(4):371–375.
   PubMed Web of Science ®Google Scholar
• Rizos D, Eleftheriades M, Batakis E, et al. Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby. J Matern Fetal Neonatal Med. 2012;25(8):1311–1315.
   PubMed Web of Science ®Google Scholar
• Holden DP, Fickling SA, Whitley GS, et al. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 1998;178(3):551–556.
   PubMed Web of Science ®Google Scholar
• Siroen MP, Teerlink T, Bolte AC, et al. No compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia. Gynecol Obstet Invest. 2006;62(1):7–13.
   PubMed Web of Science ®Google Scholar
• Sandrim VC, Palei AC, Metzger IF, et al. Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia. Clin Chim Acta. 2010;411(19–20):1457–1460.
   PubMed Web of Science ®Google Scholar
• Bian Z, Shixia C, Duan T. First-trimester maternal serum levels of sFLT1, PGF and ADMA predict preeclampsia. PLoS One. 2015;10(4):e0124684.
   PubMed Web of Science ®Google Scholar
• Ehsanipoor RM, Fortson W, Fitzmaurice LE, et al. Nitric oxide and carbon monoxide production and metabolism in preeclampsia. Reprod Sci. 2013;20(5):542–548.
   PubMed Web of Science ®Google Scholar
• Maeda T, Yoshimura T, Okamura H. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation. J Soc Gynecol Investig. 2003;10(1):2–4.
   PubMedGoogle Scholar
• Khalil AA, Tsikas D, Akolekar R, et al. Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks' gestation and preeclampsia: a case-control study. J Hum Hypertens. 2013;27(1):38–43.
   PubMed Web of Science ®Google Scholar
• Böger RH, Diemert A, Schwedhelm E, et al. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia. Gynecol Obstet Invest. 2010;69(1):1–13.
   PubMed Web of Science ®Google Scholar
• Arcos MI, Fujihara CK, Sesso A, et al. Mechanisms of albuminuria in the chronic nitric oxide inhibition model. Am J Physiol Renal Physiol. 2000;279(6):1060–1066.
   Web of Science ®Google Scholar
• Kaida Y, Ueda S, Yamagishi S, et al. Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome. Life Sci. 2012;91(9–10):301–305.
   PubMed Web of Science ®Google Scholar
• Caglar K, Yilmaz MI, Sonmez A, et al. ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney Int. 2006;70(4):781–787.
   PubMed Web of Science ®Google Scholar
• Sonmez A, Celebi G, Erdem G, et al. Plasma apelin and ADMA Levels in patients with essential hypertension. Clin Exp Hypertens. 2010;32(3):179–183.
   PubMed Web of Science ®Google Scholar
• Dong X, Gou W, Li C, et al. Proteinuria in preeclampsia: not essential to diagnosis but related to disease severity and fetal outcomes. Pregnancy Hypertens. 2017;8:60–64.
   PubMed Web of Science ®Google Scholar
• Baylis C. Nitric oxide synthase derangements and hypertension in kidney disease. Curr Opin Nephrol Hypertens. 2012;21(1):1–6.
   PubMed Web of Science ®Google Scholar
• Briet M, Burns KD. Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. Clin Sci (Lond). 2012;123(7):399–416.
   PubMed Web of Science ®Google Scholar